SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-029577
Filing Date
2020-10-28
Accepted
2020-10-28 20:51:02
Documents
2
Period of Report
2020-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2970
2 EX-24 DOCUMENT attachment1.htm EX-24 4826
  Complete submission text file 0000899243-20-029577.txt   9189
Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto Inc. (Issuer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALECTO, INC. OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address
Lindmark Bertil (Reporting) CIK: 0001825778 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 201270180